Zheng, Y.; Gao, Q.; Su, X.; Xiao, C.; Yu, B.; Huang, S.; Sun, Y.; Wu, S.; Wo, Y.; Xu, Q.;
et al. Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy. Cancers 2022, 14, 4970.
https://doi.org/10.3390/cancers14204970
AMA Style
Zheng Y, Gao Q, Su X, Xiao C, Yu B, Huang S, Sun Y, Wu S, Wo Y, Xu Q,
et al. Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy. Cancers. 2022; 14(20):4970.
https://doi.org/10.3390/cancers14204970
Chicago/Turabian Style
Zheng, Yulong, Qiqi Gao, Xingyun Su, Cheng Xiao, Bo Yu, Shenglin Huang, Yifeng Sun, Sheng Wu, Yixin Wo, Qinghua Xu,
and et al. 2022. "Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy" Cancers 14, no. 20: 4970.
https://doi.org/10.3390/cancers14204970
APA Style
Zheng, Y., Gao, Q., Su, X., Xiao, C., Yu, B., Huang, S., Sun, Y., Wu, S., Wo, Y., Xu, Q., Xu, N., & Yu, H.
(2022). Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy. Cancers, 14(20), 4970.
https://doi.org/10.3390/cancers14204970